Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001301396-24-000005·BIORA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
BIORA THERAPEUTICS INC
Biora Therapeutics, Inc. Common Stock · CUSIP: 74319F305
Event date: 2024-03-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Context Capital Management, LLC
Shares: 2,989,698.00 · Class: 9.9%
- Michael S. Rosen
Shares: 2,989,698.00 · Class: 9.9%
- William D. Fertig
Shares: 2,989,698.00 · Class: 9.9%
- Charles E. Carnegie
Shares: 2,989,698.00 · Class: 9.9%
- Context Partners Master Fund, L.P.
Shares: 2,989,698.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001301396-24-000005
- Form type
- SCHEDULE 13G
- Filer
- BIORA THERAPEUTICS, INC.
- CIK
- CIK 1580063
- Filed
- Mar 20, 2024
- Reporting period
- Mar 12, 2024
- Description
- Schedule 13G beneficial ownership